SAN DIEGO, Feb. 7, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will provide a corporate presentation on Monday, February 13 at 3:30 p.m. (EST) at the 14th Annual BIO CEO & Investor Conference. The presentation will take place at the Waldorf Astoria in New York.
